The Integration of Traditional Medicine with Conventional Biomedicine: A Narrative Review of the Japanese Perspective

Abstract

Objectives: This is a narrative review of the integration of traditional medicine with conventional biomedicine in present day Japan, whose aging population is considered one of the largest globally. Design: It is focused on the aging population because this age group most avails of healthcare. We also tried to describe the unique Japanese medical situations, clinical outcome of Japanese traditional medicine (Kampo medicine) which may include acupuncture, and education of Kampo medicine workforce. Results: Conventional schools of medicine in Japan are required to teach Kampo medicine, and most Japanese physicians (>80%) prescribe traditional medicine, especially in primary care settings. The universal national healthcare system covers Kampo medicine prescribed by physicians and treatment by acupuncturists (they sometimes refer patients who may need evaluation by physicians), enhancing access to primary healthcare. Additionally, pharmacists who graduated from conventional schools of pharmacy also select and sell Kampo medicine as over-the-counter (OTC) medication. Kampo medicine available as prescription drugs and OTC is effective, and has been proven to be economically beneficial in several clinical settings. Conclusions: An aging population is a global concern for both developed and developing countries. Japan, having a significantly-large aging population, integrates conventional biomedicine and traditional medicine in its universal national healthcare coverage, through its biomedically-trained physicians and pharmacists who also learned traditional medicine, as well as the acupuncturists. By reviewing the current situation in Japan, the authors hope to introduce the future of the global contribution of traditional, complementary, and integrative medicine in primary care.

Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational study

“…[19,20] Typically, Japan's national health insurance system covers these fixed-recipe, lower-dosage products prescribed by conventional biomedicine physicians. [21] KBG comprises Japanese Pharmacopoeia (JP) cinnamon bark, peony root, peach kernel, Poria sclerotium, and Moutan bark. [22] TSS consists of JP Japanese Angelica root, Cnidium rhizome, peony root, Poria sclerotium, Atractylodes lancea rhizome, and Alisma tuber.…”

“…[ 19 , 20 ] Typically, Japan’s national health insurance system covers these fixed-recipe, lower-dosage products prescribed by conventional biomedicine physicians. [ 21 ]…”